Excerpt
In our present work, we can demonstrate that Lef-1 is overexpressed in pancreatic cancer. Additionally, Lef-1 is able to reduce the expression of E-cadherin on protein and RNA-expression levels, using a new splice variant. In contrast, P-cadherin expression levels are elevated in pancreatic cancer. Overexpressed Lef-1 is able to enhance the expression of P-cadherin, which is due to transcriptional activation of the P-cadherin promoter.
The inverse regulation of E- and P-cadherin is probably caused by increased expression of Lef-1, as we could show that in cells with a high expression level of Lef-1 and P-cadherin as well as a marginal expression of E-cadherin (SW480), overexpression of dominant negative Lef-1 (Lef-1 ΔHMG) reduces P-cadherin protein levels and inversely enhances E-cadherin protein levels.
Additionally, pancreatic cancer cells overexpressing Lef-1 - resulting in increased P-cadherin and reduced E-cadherin expression - show a reduced cellular aggregation.